Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Natus Medical Inc Issues Q3 2013 Outlook; Revenue Outlook Below Analysts' Estimates; Issues Q4 2013 Outlook Below Analysts' Estimates; Lowers FY 2013 Outlook; Issues Q3 2013 Charge Outlook


Thursday, 1 Aug 2013 07:00am EDT 

Natus Medical Inc announced that for the third quarter 2013, it expects to report revenue of $80 million to $82 million and non-GAAP earnings per share of $0.18 to $0.21. For the fourth quarter 2013, the Company expects to report revenue of $84 million to $88 million and non-GAAP earnings per share of $0.22 to $0.25. For fiscal 2013 the Company expects to report revenue of $332 million to $338 million and non-GAAP earnings per share (EPS) of $0.76 to $0.82. The Company expects to record a restructuring charge of approximately $2 million during the third quarter 2013 associated with a plan to restructure and streamline operations and reduce costs. Non-GAAP earnings per share estimates do not include these estimated restructuring charges. The Company's fiscal 2013 and quarterly non-GAAP earnings per share guidance exclude amortization of acquisition related intangibles, acquisition related charges, restructuring charges, and their related tax effects. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $85 million and EPS of $0.18 for the third quarter of 2013; revenue of $95 million and EPS of $0.30 for the fourth quarter of 2013; and revenue of $352 million and EPS of $0.76 for fiscal 2013. 

Company Quote

38.72
 --
1 May 2015